900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
pT2d (UICC)	Preferred (foundation metadata concept)
pT3 (AJCC)	Preferred (foundation metadata concept)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri)	Preferred (foundation metadata concept)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva)	Preferred (foundation metadata concept)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) (finding)	Preferred (foundation metadata concept)
pT3 (UICC)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) (finding)	Preferred (foundation metadata concept)
pT3 category	Preferred (foundation metadata concept)
pT3 category (finding)	Preferred (foundation metadata concept)
pT3 stage	Acceptable (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (bone)	Preferred (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (bone) (finding)	Preferred (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT3: Extraprostatic extension (prostate)	Preferred (foundation metadata concept)
pT3: Extraprostatic extension (prostate) (finding)	Preferred (foundation metadata concept)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin)	Preferred (foundation metadata concept)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding)	Preferred (foundation metadata concept)
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts)	Preferred (foundation metadata concept)
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) (finding)	Preferred (foundation metadata concept)
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma)	Preferred (foundation metadata concept)
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT3: Tumor >5 cm in greatest dimension (breast)	Acceptable (foundation metadata concept)
pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma)	Preferred (foundation metadata concept)
pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas)	Preferred (foundation metadata concept)
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) (finding)	Preferred (foundation metadata concept)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota fascia (kidney)	Acceptable (foundation metadata concept)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney)	Preferred (foundation metadata concept)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) (finding)	Preferred (foundation metadata concept)
pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus)	Preferred (foundation metadata concept)
pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) (finding)	Preferred (foundation metadata concept)
pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands)	Preferred (foundation metadata concept)
pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades adventitia (esophagus)	Preferred (foundation metadata concept)
pT3: Tumor invades adventitia (esophagus) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus)	Preferred (foundation metadata concept)
pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat (ureter)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat (ureter) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis)	Preferred (foundation metadata concept)
pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades pancreas (ampulla of Vater)	Preferred (foundation metadata concept)
pT3: Tumor invades pancreas (ampulla of Vater) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades perivesical tissue (urinary bladder)	Preferred (foundation metadata concept)
pT3: Tumor invades perivesical tissue (urinary bladder) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts)	Preferred (foundation metadata concept)
pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis)	Preferred (foundation metadata concept)
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix)	Preferred (foundation metadata concept)
pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum)	Preferred (foundation metadata concept)
pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) (finding)	Preferred (foundation metadata concept)
pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine)	Preferred (foundation metadata concept)
pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) (finding)	Preferred (foundation metadata concept)
pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma)	Preferred (foundation metadata concept)
pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma)	Acceptable (foundation metadata concept)
pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) (finding)	Preferred (foundation metadata concept)
pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx)	Preferred (foundation metadata concept)
pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx) (finding)	Preferred (foundation metadata concept)
pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis)	Preferred (foundation metadata concept)
pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis)	Preferred (foundation metadata concept)
pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis)	Preferred (foundation metadata concept)
pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis) (finding)	Preferred (foundation metadata concept)
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx)	Preferred (foundation metadata concept)
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma)	Preferred (foundation metadata concept)
pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm in greatest dimension (oropharynx)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm in greatest dimension (oropharynx) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid)	Preferred (foundation metadata concept)
pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 5 cm in greatest dimension (anal canal)	Preferred (foundation metadata concept)
pT3: Tumor more than 5 cm in greatest dimension (anal canal) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 5 cm in greatest dimension (breast)	Preferred (foundation metadata concept)
pT3: Tumor more than 5 cm in greatest dimension (breast) (finding)	Preferred (foundation metadata concept)
pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	Preferred (foundation metadata concept)
pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)	Preferred (foundation metadata concept)
pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach)	Preferred (foundation metadata concept)
pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach) (finding)	Preferred (foundation metadata concept)
pT3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder)	Preferred (foundation metadata concept)

Start Previous Page 13245 of 13262 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)